Coronary care - Nursing Case Study

Pathophysiology

• Primary mechanism: Atherosclerosis involves the buildup of plaque (cholesterol, fatty substances) in coronary arteries, leading to narrowed vessel lumens and reduced blood flow to the heart muscle, causing ischemia and chest pain (angina).

• Secondary mechanism: Plaque rupture and subsequent thrombosis can occlude coronary arteries entirely, leading to myocardial infarction (heart attack) as heart tissue is deprived of oxygen, causing cell death and impaired cardiac function.

• Key complication: Reduced blood supply and oxygenation can lead to heart failure, arrhythmias, or cardiac arrest, emphasizing the need for prompt intervention to restore blood flow and minimize myocardial damage.

Patient Profile

Demographics:

65-year-old male, retired construction worker

History:

• Key past medical history: Hypertension, Type 2 Diabetes, previous myocardial infarction 3 years ago

• Current medications: Metoprolol, Lisinopril, Metformin, Aspirin

• Allergies: Penicillin

Current Presentation:

• Chief complaint: Chest pain and shortness of breath

• Key symptoms: Increasing chest tightness over the past 24 hours, fatigue, dizziness, mild edema in lower extremities

• Vital signs: Blood pressure 150/95 mmHg, Heart rate 110 bpm, Respiratory rate 22 breaths per minute, Temperature 98.6°F, Oxygen saturation 92% on room air

Section 1

As the medical team continues to assess the patient, further diagnostic tests are promptly conducted to evaluate the severity of his condition and guide treatment decisions. An electrocardiogram (ECG) reveals ST-segment elevation in the anterior leads, suggesting an acute ST-elevation myocardial infarction (STEMI). Cardiac biomarkers, including troponin levels, are significantly elevated, confirming myocardial injury. A chest X-ray shows mild pulmonary congestion, indicative of early heart failure due to compromised cardiac function. The patient's echocardiogram demonstrates reduced ejection fraction, suggesting impaired left ventricular function. These findings highlight the need for urgent intervention to restore coronary blood flow and prevent further myocardial damage.

Despite initial medical management with aspirin, nitroglycerin, and heparin, the patient's condition deteriorates. He experiences increasing chest pain and worsening shortness of breath. His oxygen saturation decreases to 88% on room air, and auscultation reveals crackles at the lung bases, indicating pulmonary edema. Concerned about the progression to cardiogenic shock, the healthcare team decides to transfer the patient to the catheterization lab for an emergency percutaneous coronary intervention (PCI) to reopen the blocked coronary artery. This decision is critical to alleviating ischemic symptoms, improving cardiac function, and stabilizing the patient's hemodynamic status.

Following the PCI, the patient is closely monitored in the coronary care unit. Although the procedure successfully restores coronary perfusion, the patient remains at risk for potential complications, such as arrhythmias or recurrent ischemic events. Continuous telemetry monitoring is initiated to detect any changes in cardiac rhythm or further deterioration. The healthcare team must remain vigilant and prepared to address any new challenges that may arise during the recovery period, ensuring that the patient receives optimal care to improve his prognosis and quality of life.

Section 2

As the patient settles into the coronary care unit post-PCI, the healthcare team remains vigilant in monitoring for complications. Within the first six hours, the patient begins to exhibit signs of hemodynamic instability. His blood pressure drops to 85/50 mmHg, heart rate escalates to 120 beats per minute, and he becomes increasingly diaphoretic and restless. These changes indicate a potential progression to cardiogenic shock, despite the restoration of coronary blood flow. The team quickly assesses the patient's fluid status and considers the need for inotropic support to augment cardiac output and stabilize his blood pressure.

Concurrently, laboratory results reveal a further elevation in troponin levels, indicating ongoing myocardial injury. The patient's renal function tests show an increase in creatinine from 1.0 mg/dL to 1.7 mg/dL, suggesting acute kidney injury likely due to decreased perfusion and contrast-induced nephropathy from the PCI. This development necessitates careful fluid management and consideration of renal-protective strategies to prevent further deterioration of kidney function.

In response to these challenges, the medical team initiates a low-dose infusion of dobutamine to support cardiac output and administers a cautious fluid challenge under close monitoring. They also adjust the patient's medication regimen to reduce nephrotoxic risk, including holding potentially harmful agents and consulting nephrology for further guidance. As the patient continues to be monitored closely, the team prepares for potential escalation in care, which may include mechanical circulatory support, should his condition not improve with current interventions. These steps represent critical junctions in the patient's care, requiring careful clinical reasoning to balance the complexities of his evolving condition while maintaining a focus on improving his overall prognosis.

Section 3

As the medical team continues to monitor the patient closely, there is a notable change in his status. Despite the initiation of dobutamine and fluid challenges, the patient's hemodynamic parameters show only slight improvement. His blood pressure remains low at 90/55 mmHg, and his heart rate is now fluctuating between 115 and 130 beats per minute. Additionally, the patient reports new-onset chest discomfort and appears more lethargic, prompting further investigation into the cause of his persistent instability.

The team orders an urgent echocardiogram to assess cardiac function more comprehensively. The echocardiogram reveals a decreased ejection fraction of 35%, suggesting significant left ventricular dysfunction. Additionally, there is evidence of mild mitral regurgitation, which could be contributing to his hemodynamic compromise. These findings, coupled with the elevated troponin levels, confirm the extent of myocardial injury and reinforce the need for ongoing inotropic support and careful management of fluid status.

In light of the new complications, the team discusses potential steps, including escalation to mechanical circulatory support if necessary. They also consider the introduction of vasopressors to further stabilize blood pressure, while maintaining a delicate balance to prevent exacerbating the renal injury. A repeat set of renal function tests shows a creatinine level of 1.9 mg/dL, underscoring the importance of nephrology input in managing his kidney function. The evolving situation requires not only immediate clinical interventions but also strategic planning to anticipate the patient's needs as his condition remains precarious. The team remains vigilant, ready to adapt their approach as they strive to stabilize the patient and improve his overall prognosis.

Section 4

As the medical team continues to manage the patient's care, they observe a change in his status that prompts further investigation. The patient's chest discomfort intensifies, and he becomes increasingly diaphoretic and dyspneic. Vital signs reveal that his heart rate has risen to 140 beats per minute, and his blood pressure has decreased to 85/50 mmHg, indicating worsening hemodynamic instability. The team notes that he is developing cool, clammy skin, and his peripheral pulses are weak and thready, suggesting inadequate perfusion.

In response to these alarming signs, the team decides to perform an urgent arterial blood gas analysis and a 12-lead ECG. The blood gas results show a pH of 7.29, a partial pressure of carbon dioxide (PaCO2) of 52 mmHg, and a bicarbonate level of 18 mEq/L, indicating a mixed respiratory and metabolic acidosis. The ECG reveals new ST-segment depressions in the lateral leads, consistent with ongoing ischemia or infarction. These findings suggest that the patient's myocardial supply-demand mismatch is worsening, despite the current interventions.

Recognizing the gravity of the situation, the team concludes that immediate adjustments to the treatment plan are necessary. They initiate low-dose norepinephrine to support his blood pressure and consider the timing for potential mechanical circulatory support interventions such as an intra-aortic balloon pump. Additionally, nephrology is consulted to evaluate the renal implications of ongoing hypotension and to assist in optimizing fluid management strategies. The team remains focused on preventing further complications while continuing to monitor the patient's response closely, aiming to stabilize his condition and prevent further deterioration.

Section 5

As the medical team implements the adjusted treatment plan, they closely monitor the patient's response to the interventions. Initially, the low-dose norepinephrine infusion appears to stabilize the patient's blood pressure, which rises to 95/60 mmHg. However, despite the slight improvement in hemodynamics, the patient continues to experience significant chest discomfort and exhibits pronounced dyspnea. Repeat vital signs indicate a persistent tachycardia, with the heart rate hovering around 135 beats per minute. The patient's respiratory rate remains elevated at 28 breaths per minute, and his oxygen saturation fluctuates between 88-90% on supplemental oxygen.

Concerned about the potential for further ischemic damage and recognizing the persistence of respiratory distress, the team decides to conduct another 12-lead ECG and perform a follow-up echocardiogram. The repeat ECG continues to show ST-segment depressions in the lateral leads, and new findings now include T-wave inversions in the inferior leads, suggesting an evolving ischemic process. The echocardiogram reveals a reduction in left ventricular ejection fraction to 35%, indicating compromised cardiac function. Additionally, the echocardiogram identifies mild mitral regurgitation, likely secondary to papillary muscle dysfunction from the ongoing ischemia.

In light of these developments, the team deliberates on the need for more aggressive intervention. They discuss the possibility of initiating mechanical circulatory support to improve cardiac output and reduce myocardial workload. Nephrology's evaluation highlights a decrease in urine output to 15 mL/hr, raising concerns about acute kidney injury secondary to prolonged hypotension. This prompts the team to carefully reassess the patient's fluid status and consider initiating a cautious fluid resuscitation strategy. As they navigate these complex clinical decisions, the team remains vigilant, understanding that timely interventions are crucial to halting the progression of the patient's condition and averting further complications.